首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Histopathological findings in the iris of dapsone treated leprosy patients.
【2h】

Histopathological findings in the iris of dapsone treated leprosy patients.

机译:氨苯砜治疗麻风病人虹膜的组织病理学发现。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

From 43 Nepalese leprosy patients skin smear negative, and treated with dapsone (diamino diphenyl sulphone), and without any sign of active leprosy or iritis, specimens from iridectomy during cataract surgery were studied histopathologically. Of 49 iris specimens only six (12%) were found to be without any histopathological change. Atrophy of the iris stroma was seen in 63% and neovascularisation in 6% of all cases. In 16% in which the dilator muscle could be detected, it was atrophic, and in 11% the pigmented epithelium was thinned and atrophic. Cellular inflammatory infiltrations were seen in 88% of all specimens. They were mostly slight in eyes which before operation had been without posterior synechiae of the iris. In most of the eyes in which posterior synechiae had been present moderate or heavy inflammatory cell infiltrates composed of lymphocytes and plasma cells, often associated with macrophages, neutrophils, or eosinophils, were found. In five iris specimens acid fast bacilli were present. This raises the question whether these can survive systemically despite dapsone chemotherapy in the iris, thus leading to dapsone-resistant leprosy and to recurrent iritis.
机译:从43名尼泊尔麻风病人的皮肤涂片阴性,并用氨苯砜(二氨基二苯砜)治疗,没有任何活动性麻风或虹膜炎的迹象,对白内障手术期间虹膜切除术的标本进行了组织病理学研究。在49个虹膜标本中,只有6个(12%)没有任何组织病理学改变。在所有病例中,虹膜基质萎缩占63%,新生血管形成占6%。在可检测到扩张肌的16%中,它是萎缩的;在11%中,有色上皮变薄且萎缩。在所有标本中有88%可见细胞炎性浸润。他们的眼睛大部分是轻微的,在手术前没有虹膜后粘连。在大多数存在后粘连的眼睛中,发现了由淋巴细胞和浆细胞组成的中度或重度炎性细胞浸润,通常与巨噬细胞,嗜中性粒细胞或嗜酸性粒细胞有关。在五个虹膜标本中存在耐酸杆菌。这就提出了一个问题,尽管虹膜中进行了氨苯砜化学治疗,这些药物是否可以全身存活,从而导致耐氨苯砜的麻风病和复发性虹膜炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号